| Osteoporosis Reimbursement Policy: United States of America, Europe and Korea |
| 골다공증 보험급여기준: 미국, 유럽, 한국 |
| 최형진,윤현구,신찬수 |
| 서울대학교 의과대학 내과학교실, 관동대학교 의과대학 내과학교실1 |
|
|
| Abstract |
|
Osteoporosis and its related fractures have become a rapidly increasing health problem in Korea. Osteoporosis
reimbursement policy is an essential part of public health effort to control this national threat. The osteoporosis
reimbursement policies of United Stated of America, Europe and Korea are discussed. Medicare, the social insurance
program in United States of America, provides a national reimbursement program for bone mineral density measurements.
However, regarding the osteoporosis medicines in United States of America, the reimbursement policy will vary widely
according to the district of residence and the insurance plan of the patient. In Europe, most of countries have a national
reimbursement policy that covers bone mineral density measurements and medicines for osteoporosis. The criteria for
reimbursement of osteoporosis medicines are T-score ≤ -2.5 and/or other risk factors, in general. And in some European
countries, the criterion for T-score is ≤ -3.0. The reimbursement policy of bone mineral density measurements and
osteoporosis medicine in Korea is similar or slightly narrower compared to that of European countries. And the
reimbursement criteria for osteoporosis medicine in Korea do not include other risk factors (beside T-score), in contrast
to that of European countries. [Korean Journal of Bone Metabolism, 17(1): 7-12, 2010] |
| Key Words:
Osteoporosis, Reimbursement, USA, Europe, Korea |
|
PDF Links
Full text via DOI
Download Citation
